Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination

por Gelbenegger, Georg, Cacioppo, Filippo, Firbas, Christa, Jilma, Bernd
Publicado 2021

Surface cooling for induction of mild hypothermia in conscious healthy volunteers - a feasibility trial

por Testori, Christoph, Sterz, Fritz, Behringer, Wilhelm, Spiel, Alexander, Firbas, Christa, Jilma, Bernd
Publicado 2011

High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm

por Roetzer, Andreas, Stich, Norbert, Model, Nina, Schwameis, Michael, Firbas, Christa, Jilma, Bernd, Eibl, Martha M.
Publicado 2020

Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial

por Buchtele, Nina, Schwameis, Michael, Schoergenhofer, Christian, Derhaschnig, Ulla, Firbas, Christa, Karch, Rudolf, Nix, Darrell, Schenk, Roman, Jilma, Bernd
Publicado 2020

Defibrotide enhances fibrinolysis in human endotoxemia – a randomized, double blind, crossover trial in healthy volunteers

por Schoergenhofer, Christian, Buchtele, Nina, Gelbenegger, Georg, Derhaschnig, Ulla, Firbas, Christa, Kovacevic, Katarina D., Schwameis, Michael, Wohlfarth, Philipp, Rabitsch, Werner, Jilma, Bernd
Publicado 2019

A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway

por Bartko, Johann, Schoergenhofer, Christian, Schwameis, Michael, Firbas, Christa, Beliveau, Martin, Chang, Colin, Marier, Jean‐Francois, Nix, Darrell, Gilbert, James C., Panicker, Sandip, Jilma, Bernd
Publicado 2018

Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans

por Samekova, Karolina, Firbas, Christa, Irrgeher, Johanna, Opper, Christine, Prohaska, Thomas, Retzmann, Anika, Tschegg, Cornelius, Meisslitzer, Claudia, Tchaikovsky, Anastassiya, Gouya, Ghazaleh, Freissmuth, Michael, Wolzt, Michael
Publicado 2021

Dose‐dependent naloxone‐induced morphine withdrawal symptoms in opioid‐dependent males—a double‐blinded, randomized study

por Weisshaar, Stefan, Brandt, Laura, Litschauer, Brigitte, Sheik‐Rezaei, Safoura, Moser, Laura, Nirnberger, Günther, Kühberger, Elisabeth, Bauer, Ulrike, Firbas, Christa, Gouya, Ghazaleh, Wolzt, Michael, Fischer, Gabriele
Publicado 2020

Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing

por Schoergenhofer, Christian, Schwameis, Michael, Firbas, Christa, Bartko, Johann, Derhaschnig, Ulla, Mader, Robert M, Plaßmann, Raute Sunder, Jilma-Stohlawetz, Petra, Desai, Kalpna, Misra, Priya, Jäger, Ulrich, Jilma, Bernd
Publicado 2018

The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial

por Kovacevic, Katarina D., Grafeneder, Jürgen, Schörgenhofer, Christian, Gelbenegger, Georg, Gager, Gloria, Firbas, Christa, Quehenberger, Peter, Jilma-Stohlawetz, Petra, Bileck, Andrea, Zhu, Shuhao, Gilbert, James C., Beliveau, Martin, Jilma, Bernd, Derhaschnig, Ulla
Publicado 2021

Enriched stable (204)Pb as tracer at ultra-low levels in clinical investigations

por Irrgeher, Johanna, Berger, Thomas, Tchaikovsky, Anastassiya, Tschegg, Cornelius, Gouya, Ghazaleh, Lechner, Peter, Retzmann, Anika, Opper, Christine, Firbas, Christa, Freissmuth, Michael, Peschel-Credner, Kerstin, Anderle, Karolina, Meisslitzer, Claudia, Wolzt, Michael, Prohaska, Thomas
Publicado 2022

Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxin...

por Magyarics, Zoltan, Leslie, Fraser, Bartko, Johann, Rouha, Harald, Luperchio, Steven, Schörgenhofer, Christian, Schwameis, Michael, Derhaschnig, Ulla, Lagler, Heimo, Stiebellehner, Leopold, Firbas, Christa, Weber, Susanne, Campanaro, Ed, Jilma, Bernd, Nagy, Eszter, Stevens, Chris
Publicado 2019

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

por Ay, Cihan, Kovacevic, Katarina D., Kraemmer, Daniel, Schoergenhofer, Christian, Gelbenegger, Georg, Firbas, Christa, Quehenberger, Peter, Jilma-Stohlawetz, Petra, Gilbert, James C., Zhu, Shuhao, Beliveau, Martin, Koenig, Franz, Iorio, Alfonso, Jilma, Bernd, Derhaschnig, Ulla, Pabinger, Ingrid
Publicado 2023

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial

por Eskandary, Farsad, Dürr, Michael, Budde, Klemens, Doberer, Konstantin, Reindl-Schwaighofer, Roman, Waiser, Johannes, Wahrmann, Markus, Regele, Heinz, Spittler, Andreas, Lachmann, Nils, Firbas, Christa, Mühlbacher, Jakob, Bond, Gregor, Halloran, Philipp F., Chong, Edward, Jilma, Bernd, Böhmig, Georg A.
Publicado 2019

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial

por Mayer, Katharina A., Budde, Klemens, Halloran, Philip F., Doberer, Konstantin, Rostaing, Lionel, Eskandary, Farsad, Christamentl, Anna, Wahrmann, Markus, Regele, Heinz, Schranz, Sabine, Ely, Sarah, Firbas, Christa, Schörgenhofer, Christian, Kainz, Alexander, Loupy, Alexandre, Härtle, Stefan, Boxhammer, Rainer, Jilma, Bernd, Böhmig, Georg A.
Publicado 2022

Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study

por Pereyra, David, Heber, Stefan, Schrottmaier, Waltraud C, Santol, Jonas, Pirabe, Anita, Schmuckenschlager, Anna, Kammerer, Kerstin, Ammon, Daphni, Sorz, Thomas, Fritsch, Fabian, Hayden, Hubert, Pawelka, Erich, Krüger, Philipp, Rumpf, Benedikt, Traugott, Marianna T, Glaser, Pia, Firbas, Christa, Schörgenhofer, Christian, Seitz, Tamara, Karolyi, Mario, Pabinger, Ingrid, Brostjan, Christine, Starlinger, Patrick, Weiss, Günter, Bellmann-Weiler, Rosa, Salzer, Helmut J F, Jilma, Bernd, Zoufaly, Alexander, Assinger, Alice
Publicado 2021

A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation

por Heber, Stefan, Pereyra, David, Schrottmaier, Waltraud C., Kammerer, Kerstin, Santol, Jonas, Rumpf, Benedikt, Pawelka, Erich, Hanna, Markus, Scholz, Alexander, Liu, Markus, Hell, Agnes, Heiplik, Klara, Lickefett, Benno, Havervall, Sebastian, Traugott, Marianna T., Neuböck, Matthias J., Schörgenhofer, Christian, Seitz, Tamara, Firbas, Christa, Karolyi, Mario, Weiss, Günter, Jilma, Bernd, Thålin, Charlotte, Bellmann-Weiler, Rosa, Salzer, Helmut J. F., Szepannek, Gero, Fischer, Michael J. M., Zoufaly, Alexander, Gleiss, Andreas, Assinger, Alice
Publicado 2022